Clinical Management of Advanced Prostate Cancer: Where Does Radiopharmaceutical Therapy Fit in the Treatment Algorithm?
P Viscuse, M Devitt, R Dreicer - Journal of Nuclear Medicine, 2024 - Soc Nuclear Med
Most men with newly appreciated metastatic prostate cancer are optimally treated with a
backbone consisting of androgen receptor–directed therapy with or without taxane …
backbone consisting of androgen receptor–directed therapy with or without taxane …
Adoption of Lutetium-177 PSMA radioligand therapy for metastatic castration resistant prostate cancer: a total population analysis in Germany from 2016 to 2020
L Flegar, SG Thoduka, D Librizzi, M Luster… - European Journal of …, 2023 - Springer
Purpose This study is to investigate the adoption and current trends of Lutetium-177 PSMA
RLT for mCRPC in Germany. Methods We analyzed data from the reimbursement. INFO tool …
RLT for mCRPC in Germany. Methods We analyzed data from the reimbursement. INFO tool …
Bone marrow dosimetry in low volume mHSPC patients receiving Lu-177-PSMA therapy using SPECT/CT
D Grob, BM Privé, CHJ Muselaers, N Mehra… - EJNMMI physics, 2024 - Springer
Background Bone marrow toxicity in advanced prostate cancer patients who receive [177Lu]
Lu-PSMA-617 is a well-known concern. In early stage patients; eg low volume metastatic …
Lu-PSMA-617 is a well-known concern. In early stage patients; eg low volume metastatic …
Radioligand therapy with 177Lu-PSMA-I&T in patients with metastatic prostate cancer: oncological outcomes and toxicity profile
Results In mCRPC, 22 (69%), 18 (56%), and 11 (34%) patients achieved any PSA decline,
PSA response of≥ 30%, and PSA response of≥ 50%, respectively. The clinical progression …
PSA response of≥ 30%, and PSA response of≥ 50%, respectively. The clinical progression …
Theranostics in prostaatkanker
BM Privé, CHJ Muselaers, SMB Peters… - Tijdschrift voor …, 2024 - Springer
In de afgelopen jaren wordt de term 'theranostics' steeds vaker gebruikt. Een nieuwe, reeds
welbekende, theranostic of radioligand-therapie (RLT) is 177Lu-PSMA, waarmee patiënten …
welbekende, theranostic of radioligand-therapie (RLT) is 177Lu-PSMA, waarmee patiënten …